Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831334 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
A Early Phase 1 study of Permanent Chemotherapy-induced Alopecia, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03831334 is a Early Phase 1 study of Permanent Chemotherapy-induced Alopecia that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03831334, a Early Phase 1 study of Permanent Chemotherapy-induced Alopecia, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.
Conditions Studied
Interventions
- DRUG oral minoxidil
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2025-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03831334
The ClinicalTrials.gov registry entry for NCT03831334 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Permanent Chemotherapy-induced Alopecia appearing as the primary indexed condition, and to 1 intervention - of which oral minoxidil is the first listed.
NCT03831334 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03831334 about?
NCT03831334 is a clinical study titled "Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia". An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.
What is the current status of trial NCT03831334?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2019-04-09. Estimated completion is 2025-08.
What conditions does trial NCT03831334 study?
This clinical trial studies the following conditions: Permanent Chemotherapy-induced Alopecia.
What interventions are being tested in trial NCT03831334?
The interventions under investigation include: oral minoxidil (DRUG).
Who is sponsoring clinical trial NCT03831334?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03831334 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.